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If pathophysiology were a fan propeller, cell death would
constitute the pivot. Indeed, most diseases are connected to
deregulated cell death in some way. Excessive, unwarranted
cell death accounts for pathological cell loss, be it slowly
degenerative as in Alzheimer’s disease or dramatically acute
as in stroke and myocardial infarction. Infectious pathogens
manipulate cell death pathways to induce or inhibit the death
of host cells at will and to subvert the immune recognition of
‘dangerous’ cell death. Finally, cancer is inexorably linked to a
partial suppression of cell death programs in tumor cells,
although therapy aims to (re)activate such lethal programs.
Cell Death and Disease, a new open-access, online journal
aimstoprovidecenterstagetofundamental,disease-oriented
and translational research in cell death.
By the end of the last millennium, cell death research had
developed into a discipline of its own, with speciﬁc
societies – the International Cell Death Society (www.
celldeath-apoptosis.org) and the European Cell Death
Organization (www.ecdo.eu). In 1994, Cell Death and
Differentiation – the ﬁrst journal to focus solely on cell death
– was launched. Fifteen years on, it is still the best-reputed
journal in the ﬁeld, with an impact factor to match. We hope
that Cell Death and Disease, a sister title to Cell Death and
Differentiation, will support the developing interest in the ﬁeld
and below we will outline the reasons why.
(1) Now that the main pathways of cell death have been
outlined – although not yet comprehensively – the attention of
scientists is shifting towards its translational aspects. Re-
search designed to disentangle the complex regulation and
execution of distinct cell death pathways has led to the
discovery that both lethal signaling and cell-death-associated
catabolic reactions do not only intersect with many cell-death-
unrelated processes, but also relate to multiple pathological
conditions. Just as an example, many prominent oncogenes
and tumor suppressor genes have a major and unsuspected
impact on the regulation of cell death. Similarly, pathways that
regulateprocessesapparentlyunrelatedtocelldeath,suchas
autophagy, regulation of metabolism, or organismal aging,
can have a profound inﬂuence on the propensity of cells to
undergo cell death. On the basis of these considerations, as
well as on the ethical principle that science should – sooner or
later – have a positive societal impact, we believe that it is
important to attract researchers into an area in which the
relationship between cell death and disease processes is
actively investigated and in which new, biomedically useful
insights can be gleaned from the realm of ignorance.
(2) Cell death is the ultimate (and irreversible) fate for cells
that have been damaged, exposed to lethal signals, have
failed to receive essential survival stimuli (such as nutrients,
oxygen, essential growth factors, or trophic signals from
neighboring cells), or have been intrinsically programmed for
death (as a result, for instance, of telomere erosion or other
mechanisms that ‘count’ the number of generations that a cell
is allowed to reproduce). Thus, cell death can be preceded by
a phase at which the cell is ‘diseased’, and the title of the new
journal has been designed to attract scientists who study the
behavior of deranged cells before they die. Cell Death and
Disease will publish papers dealing with cell biology research
applied to major human diseases,including (but not limited to)
neurodegenerative diseases, myopathies, mitochondrio-
pathies, infectious diseases, cancer, and pathological aging.
(3) Cell Death and Disease will promote the implementation
and utilization of systems biology (or integrated biology) by
establishing a continuum between fundamental, translational,
and clinical research. Systems biology approaches applied to
human medicine are afﬂicted by the complexity of diseases,
which are often heterogeneous entities that asynchronously
manifest in a genetically variant population. In the absence of
convenient model systems, pathology-oriented systems
biology approaches are often limited to the collection of large
data sets, without the possibility of performing multiple
perturbations that are required to understand the dynamic
properties of the system. To circumvent this problem, we
propose that we should give priority to systems biology
approaches that involve – at one or several levels – the
exploration of cultured mammalian cells. Such culture
systems are optimally suitable for the exploration of patho-
genic events within a context of manageable complexity that
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toxicological, or physical perturbations. Thus, the appropriate
use of cell biology can yield invaluable information on disease
processes, if the results are integrated with the exploration of
suitable model organisms (that include yeast, nematodes,
ﬂies, mice, and other species) and extrapolated to and
integrated with clinical datasets. This might lead to novel
diagnostic, monitoring, and therapeutic approaches.
(4) The number, quality, and impact of cell death-related
publications have steadily increased over the past two
decades. Currently, over 21000 publications, nearly 3% of
the entire scientiﬁc literature, are related to cell death, but
there is no dedicated journal that focuses on translational
aspects. STM publishing is increasingly moving online in
terms ofhow researcherssearch forandaccessthe literature,
and there is increasing support for online-only titles. This also
enables societies and publishers to investigate launching
journals in more niche areas, which might not be supported
under a traditional business model. Finally, funding agencies
are beginning to support open-access publishing in larger
numbers, and researchers – especially those working in
translational areas – want to increase access to the primary
literature. All these factors have come together to support
the launch of Cell Death and Disease: an online-only,
open-access journal that operates under the author-pays
business model.
(5) Given the explosion of scientiﬁc information, it is
important to separate accurate information from inaccurate
background. However imperfect, one way of retrieving high-
quality science is to consider its source, be it a well-reputed
author, an institution, or a journal. Cell Death and Disease
uses the long-standing experience and high reputation of its
sister journal, Cell Death and Differentiation, and the dynamic
technological platform of nature.com, with its record of top
scientiﬁc publishing. In view of this consideration, we believe
that it is essential to guarantee that papers published in
Cell Death and Disease will live up to the highest scientiﬁc
standards. For this reason, we have recruited the most
competent scientists within their specialty to the Editorial
Board of Cell Death and Disease. Their contribution to article
triage and to the selection of expert reviewers will greatly
contribute to the selection of the best articles and to their
improvement during the revision process.
Based on the aforementioned considerations, we are proud
to constitute the triumvirate of the founding Editors-in-Chief of
Cell Death and Disease. We invite our colleagues to submit
their ﬁnest research papers to this journal, which– we are
conﬁdent – will become the primary source of disease-related
cell research worldwide.
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